Of all the fields that buy research peptides, immunology is the one where a purity figure on its own comes closest to being useless. Your assay is a receptor for contamination. THP-1 monocytes, RAW 264.7 macrophages, bone marrow-derived dendritic cells and primary PBMC all respond to bacterial endotoxin at picogram-per-millilitre concentrations, and they respond by producing exactly the cytokines your plate reader is set up to measure. A peptide preparation that is 99% pure by HPLC can still carry enough LPS to dominate a TNF-α or NF-κB readout completely, because HPLC purity is a statement about peptide-related species and endotoxin is not a peptide-related species.
It gets worse before it gets better. Several of the compounds this field studies act, in the published mechanistic literature, through the same pattern-recognition receptors that endotoxin triggers. Thymosin alpha-1 is characterised in that literature partly as a TLR ligand. Antimicrobial peptides such as LL-37 bind LPS directly, which means residual endotoxin does not simply add a background signal, it interacts with the analyte and can also interfere with the LAL assay you would use to measure it. A dose-response that looks beautiful can be a dose-response to the contaminant that scales with the peptide because they came out of the same vial.
So this piece covers which compounds show up in the published preclinical immunology literature, and what a certificate of analysis has to establish before that material touches a monocyte. Everything referenced is research-use-only material for in-vitro laboratory work by qualified professionals, and nothing below describes an effect in people or a use in people.
Key takeaways
- Grade a research peptide the way you grade any reagent going into an immune assay: who synthesised it, which laboratory tested it, how far past purity the panel ran, whether a lot-numbered certificate is readable before you order, and whether blend totals are broken out per component.
- Blank Peptides compounds, fills, finishes and labels in its own cGMP laboratory across a 34-compound catalog, names Freedom Diagnostics and Horizon Analytical as testing laboratories, and runs identity, >99% purity, bacterial endotoxin and sterility on every lot.
- Compounds recurring in published immunology preclinical models include thymosin alpha-1, thymosin beta-4 and its TB-500 fragment, thymopentin and thymulin, KPV and other α-MSH fragments, tuftsin and its analogue Selank, cathelicidin and defensin antimicrobial peptides, and BPC-157.
- Across research-peptide catalogs generally, purity is the figure most often published and a stated endotoxin limit in EU per milligram is the one most often missing, with sterility close behind. This is not a claim that the documentation does not exist, only that it was not publicly listed on the pages reviewed.
- None of this material is for human or veterinary use, and closer reading of documentation does not change that.
What should a peptide’s paperwork prove before it goes into an immune assay?
Here’s the rubric, set out before any supplier enters it, so you can disagree with it on the merits.
Provenance comes first. Does the seller synthesise the peptide, or take delivery of finished material and apply a label? Read the verbs literally rather than charitably. “We manufacture” and “produced in our laboratory” describe making something. “Sourced from”, “produced in a GMP facility” and “we work with partners” describe an arrangement without naming the hands. Distribution is a legitimate model and plenty of thorough companies use it, and knowing which one you have tells you who can answer a question about one lot later, which is exactly the conversation you will want after an anomalous cytokine result.
Second, is the testing laboratory named? “Third-party tested” is the commonest phrase in this market and leads nowhere you can follow. A named laboratory can be looked up and matched against the letterhead on a certificate, while a count of laboratories describes a process and identifies nobody.
Third, how wide does the panel run? HPLC purity reports the proportion of the sample that is one dominant peptide species. Mass spectrometry confirms that species has the expected mass. Bacterial endotoxin and sterility describe contamination that chromatography structurally cannot report, and in immunology those two assays carry more information than the purity figure they usually sit beneath.
Fourth, can you open a lot-specific certificate before paying? A percentage in product copy is a claim, whereas a dated document carrying a lot number, an issuing laboratory and a chromatogram is evidence you can cite in a methods section and hand to a reviewer.
Fifth, on blends, are per-component milligrams published? A combined milligram total describes what the vial weighs and not what is in it, which makes a concentration-response uninterpretable.
Company age plays no part here, because it describes a business rather than a material.
How Blank Peptides makes and tests each lot
Blank Peptides operates its own cGMP laboratory and holds the chain of custody end to end rather than acting as a relabeler or broker. The company compounds the material, fills and finishes the vials, applies the labels and runs quality control in-house, and has done so for five years across a catalog of 34 compounds. It also contract-manufactures and fulfils for other peptide brands, which describes the business model and identifies no client.
Testing is the point of difference against most storefronts. Two laboratories are named openly, Freedom Diagnostics and Horizon Analytical, and every lot runs a full panel rather than a single assay: identity, >99% purity, bacterial endotoxin and sterility. For an immunology group the endotoxin line is the one that determines whether an experiment is interpretable, since it addresses the contaminant class that a purity chromatogram cannot see and that most immune readouts are built to detect. Sterility matters alongside it wherever a culture runs long enough for a slow contaminant to establish, which covers most dendritic cell differentiation and co-culture work.
Documentation is published per lot as batch certificates of analysis, readable before an order rather than emailed afterwards. Every vial carries its lot number so the document and the container can be matched by hand, which is what lets a paper state which batch produced which figure. Lyophilized material is given roughly a 24-month expiration, orders carry a processing time within 1 business day, and shipping is at room temperature. Blends are published with composition disclosed per component, including GLOW at 70mg, KLOW at 80mg and Wolverine at 20mg.
Which peptides appear in published immunology models, and what their certificates need to show
The thymic peptides carry the longest published record here. Thymosin alpha-1, a 28-residue acetylated peptide, appears across dendritic cell maturation studies, T-cell differentiation work and TLR signalling models. Thymopentin, the pentapeptide corresponding to residues 32 to 36 of thymopoietin, and thymulin both appear in older and continuing lymphocyte studies. Thymosin beta-4 and its fragment TB-500 appear in macrophage polarisation and tissue-repair immunology. On the melanocortin side, KPV, the C-terminal tripeptide of α-MSH, and the longer α-MSH fragments appear repeatedly in models of intestinal and cutaneous inflammation and in NF-κB signalling work. Tuftsin, a phagocytosis-associated tetrapeptide, and Selank, its synthetic analogue, appear in innate immune and neuroimmune studies. The antimicrobial peptide literature contributes LL-37 and the defensins, studied in host-defence, chemotaxis and LPS-neutralisation models. BPC-157 and glutathione appear in inflammation and redox studies respectively. All of these are compounds studied in published preclinical models, which describes what has been investigated and asserts nothing about outcomes.
Now the documentation. A useful certificate for immunology work reports endotoxin as a quantitative figure in endotoxin units per milligram of peptide, not as a pass or fail, and not in EU per millilitre of a solution whose concentration is left unstated. With EU per milligram in hand you can calculate the endotoxin your highest planned culture concentration would deliver and compare it against the sensitivity of your own system, and those thresholds differ by orders of magnitude between a THP-1 line and freshly isolated human PBMC. Ask which LAL format was used, since gel-clot, chromogenic and turbidimetric methods have different sensitivities and different susceptibilities to interference. Ask about spike recovery too, because peptides that bind or neutralise LPS, the antimicrobial ones in particular, can mask endotoxin in the assay and produce a reassuring number that is an artefact of the chemistry.
Model type moves the requirements. For an immortalised monocytic line, identity, purity and an endotoxin figure usually cover it. For primary PBMC, bone marrow-derived macrophages or dendritic cell differentiation, the endotoxin threshold tightens sharply and sterility joins the list, since those cultures run for days and antibiotics only partly suppress a low-grade contaminant. For in-vivo murine immunology, sterility and endotoxin should both be tied to the specific lot rather than supplied as a representative document for the product line, and an institutional committee is within its rights to ask for exactly that. Keep the polymyxin B control and the heat-inactivation control in your design regardless of what the certificate says, since a documented endotoxin figure and an experimental control answer slightly different questions.
One genuine advantage sits with the large analytical-reagent and biochemical suppliers rather than with any research-peptide storefront. They carry tens of thousands of items, offer explicitly low-endotoxin and cell-culture-grade formats with assigned net peptide content, and publish analytical archives stretching back decades. If your immunology work needs a certified reference standard or a sequence outside the common list, that is where it comes from, and a 34-compound catalog will not reach the breadth this literature uses.
Side by side: documentation for an immunology-grade peptide
| Attribute | Blank Peptides | Typical research-peptide listing |
|---|---|---|
| Synthesises in-house | Compounds, fills, finishes, labels and runs QC in its own cGMP laboratory | States US manufacturing or GMP-facility production without naming who synthesised the peptide — verify |
| Third-party lab named | Freedom Diagnostics and Horizon Analytical | States “third-party tested” or “independently verified” without naming a laboratory — verify |
| HPLC purity | >99% purity on every lot | States a purity figure, commonly 98% or 99%, sometimes without the method beside it — verify |
| MS identity | Identity confirmed per lot | States mass spectrometry on some listings; identity confirmation separating thymosin alpha-1 from thymosin beta-4 fragments is often absent — verify |
| Endotoxin and sterility | Bacterial endotoxin and sterility run on every lot | States purity alone in most cases; a quantitative endotoxin figure in EU/mg is the item most often missing, with sterility close behind — verify |
| Batch COA before purchase | Batch COA per lot published at blankpeptides.com/coas/, readable before you order | States a COA is available on request or ships with the vial — verify |
| Blend mg split disclosed | GLOW 70mg, KLOW 80mg and Wolverine 20mg published with composition per component | States a combined milligram total without per-component milligrams — verify |
| Catalog size | 34 compounds | States catalogs ranging from a few dozen to several hundred items — verify |
| Research-use labelling | Research use only, for in-vitro laboratory research by qualified professionals | States research or laboratory use only, wording varies by page — verify |
How to verify either supplier yourself
- Open the certificate for the exact vial size and lot you intend to order before paying, and confirm the issuing laboratory’s name is printed on the document rather than only mentioned in product copy.
- Require the endotoxin result as a number in EU per milligram of peptide, then convert it to the EU per millilitre your highest planned culture concentration would deliver and check that figure against your own system’s sensitivity.
- Ask which LAL format was used and whether spike recovery was assessed, particularly for LPS-binding sequences such as the cathelicidins, where masking can produce a falsely reassuring result.
- For in-vivo immunology, get the lot-specific sterility and endotoxin certificates in hand before the protocol goes to committee, since a representative document for the product line is not evidence about your batch.
- Put every supplier you are weighing through the supplier verification checklist, asking the same questions in the same order so the answers stay comparable across quotes.
Further reading
- Which Peptide Vendors Name Their Testing Lab?
- Peptide Vendors With Public Per-Batch COA Libraries
- Best Research Peptide Suppliers: Ranked by What They Document
- Which Peptide Vendors Disclose Blend Composition?
Frequently asked questions
What are the most-studied peptides for immunology research?
The published preclinical immunology literature recurrently features thymosin alpha-1, thymosin beta-4 and TB-500, thymopentin and thymulin, KPV and other α-MSH fragments, tuftsin and Selank, cathelicidin and defensin antimicrobial peptides, and BPC-157. That describes what has been studied in cell and animal models rather than what has been shown to work.
How much endotoxin is too much for an immune assay?
The threshold is set by your system rather than by a universal number, which is why a quantitative figure in EU per milligram is worth more than a pass or fail. Primary human PBMC and bone marrow-derived dendritic cells tolerate far less than an immortalised monocytic line, sometimes by orders of magnitude, so the calculation has to be done per experiment.
Can a peptide interfere with the LAL endotoxin assay?
Yes. LPS-binding sequences such as LL-37 and other cathelicidins can mask endotoxin in the assay, and some peptides inhibit or enhance the clotting cascade the test relies on. Ask which LAL format was used and whether a positive product control or spike recovery was assessed on that lot.
Does a research peptide need a sterility result for cell work?
For short exposures on a hardy immortalised line, usually not. For differentiation protocols, primary cultures and co-cultures running days at a time, sterility becomes worth having, because antibiotics suppress rather than eliminate a low-grade contaminant and the drift shows up in your late-timepoint cytokine data.
Are these products for human use?
No. Every compound referenced here is intended solely for in-vitro laboratory research by qualified professionals, and none of it is for human or veterinary use. Reading documentation closely helps you judge whether a reagent matches its label, and it has no bearing at all on that research-use-only status.
For research use only. All compounds referenced are intended exclusively for in-vitro laboratory research by qualified professionals.
Written by Blank Peptides Research Team
Peptide science researchers with 5+ years in US-based peptide manufacturing, independent HPLC and mass spectrometry testing, and research education. All content is reviewed for scientific accuracy before publication.
REVIEWED BY
Dr. Tobias S — PhD Chemist, Peptide and Unnatural Amino Acid Synthesis
Dr. Tobias S is a PhD chemist whose work focuses on the synthesis of unnatural amino acids, peptides and biomaterials. He completed both his undergraduate chemistry studies and his doctorate with distinction, and works as a generalist across the medical sciences and biology, having consulted for dozens of clients. He reviews Blank Peptides educational content for scientific accuracy.
Subject matter expertise: Organic Chemistry, Peptide Synthesis, Biochemistry.
